Search Results

An Interview With Koen Deloose, MD

Dr. Deloose shares insights about his work in medical device development, thoughts on live case presentations and current trends in conferences, his current femoropopliteal treatment algorithm, and goals of the Belgian Society for Vascular Surgery and the Paris Vascular Insights meeting.

Bioresorbable Vascular Scaffolds: Progress and Potential

Koen Deloose, MD, discusses the potential advantages of this technology, results to date, and remaining questions to be answered.

Global Perspectives on SFA Treatment: Belgium

By Koen Deloose, MD

Around the SFA World

By Koen Deloose, MD, Guest Chief Medical Editor, and John R. Laird, MD, Chief Medical Editor

Endovascular Treatment for Long TASC C and D Lesions: Are We There Yet?

Dr. Koen Deloose talks to Dr. Martin Werner about available options, cost-effectiveness considerations, and what the future holds for complex SFA disease.

TVR Reduction in the SFA

How do current TVR reduction rates compare with earlier values?

By Koen Deloose, MD; Marc Bosiers, MD; and Joren Callaert, MD

Superficial Femoral Artery: The Forces Driving Care

By Gary M. Ansel, MD, FACC, and Koen Deloose, MD

Lesion-Specific SFA Device Selection

Key questions to consider for accurate diagnoses and tailored treatment decisions.

By Koen Deloose, MD

Absorbable Metal Stents

An update on the clinical data resulting from study of this innovative technology.

By Marc Bosiers, MD; Koen Deloose, MD; Jürgen Verbist, MD; and Patrick Peeters, MD

Peripheral Vascular Care: A Clinical and Administrative Perspective

Michael R. Jaff, DO, answers questions posed by Gary M. Ansel, MD, FACC, and Koen Deloose, MD, on the challenges of his new role as hospital president and how new regulatory and reimbursement models might affect vascular care delivery.

With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; and Koen Deloose, MD

Scoring and Cutting Balloons for SFA Disease Treatment

The role of these devices for percutaneous intervention in this challenging anatomy.

By Marc Bosiers, MD; Koen Deloose, MD; Jurgen Verbist, MD; and Patrick Peeters, MD

Clinical Application of the Xpert Stent

New data show effectiveness in the treatment of critical limb ischemia caused by infrapopliteal lesions.

By Marc Bosiers, MD; Koen Deloose, MD; Jürgen Verbist, MD; and Patrick Peeters, MD

3D Navigation in Complex TEVAR

A case report demonstrating the benefits of a three-dimensional endovascular guiding system.

By Lieven Maene, MD; Roel Beelen, MD; Patrick Peeters, MD; Jürgen Verbist, MD; Koen Keirse, MD; Koen Deloose, MD; Joren Callaert, MD; and Marc Bosiers, MD

Ask the Experts: How Do You Define ‘High Risk for Restenosis'?

With Gary M. Ansel, MD; Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Marianne Brodmann, MD; Koen Deloose, MD; Andrew Holden, MBChB, FRANZCR, EBIR; John H. Rundback, MD; and Peter A. Schneider, MD

The Catheterization Lab of the Future

An integrated interventional suite with a practical design and modern imaging equipment will save time and costs and will benefit patients and interventionists alike.

By Patrick Peeters, MD; Jürgen Verbist, MD; Koen Deloose, MD; and Marc Bosiers, MD

Ask the Experts: What Will Dominate the Next Era in SFA Therapy?

Experts discuss the current era of drug-eluting technologies and what might come next.

With Koen Deloose, MD; Craig Walker, MD; and Ramon L. Varcoe, MBBS, MS, FRACS, PhD